Stock TSOI THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Therapeutic Solutions International, Inc.

Equities

TSOI

US8833781011

Market Closed - OTC Markets
Other stock markets
 20:45:06 24/05/2024 BST 		5-day change 1st Jan Change
0.0007 USD 0.00% Intraday chart for Therapeutic Solutions International, Inc. 0.00% -30.00%
04-17 Therapeutic Solutions International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-04 Therapeutic Solutions International Receives Patent on Commercially Available QuadraMune Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Res Nova Bio Appoints George Delgado to Scientific Advisory Board
CI
Therapeutic Solutions International Appoints Navneet Boddu to Scientific Advisory Board
CI
Therapeutic Solutions International Appoints Donald Banerji to Scientific Advisory Board
CI
Therapeutic Solutions International, Inc. Appoints Francisco Silva to the Scientific Advisory Board
CI
Therapeutic Solutions International, Inc. Appoints Boris Reznik to its Advisory Board
CI
Therapeutic Solutions International, Inc. Announces Appointment of Kenji Funahashi to Campbell Neurosciences' Advisory Board
CI
Therapeutic Solutions International Appoints Dr. Boris Minev to Scientific Advisory Board
CI
Therapeutic Solutions International Appoints Serena Robella as Director of Sales
CI
Therapeutic Solutions International, Inc. Appoints J Christopher Mizer to the Advisory Board of Its Campbell Neurosciences Division
CI
Therapeutic Solutions International, Inc. Announces Resignation of Gerry B. Berg as A Member of Board of Directors, Vice President and Chief Financial Officer
CI
Therapeutic Solutions International, Inc. Appoints Feng Lin, MD, Ph.D., as Chief Scientific Officer
CI
Therapeutics Solutions International Appoints Wes Chandler to Lead the Development of its Neurostilbene Product
CI
Therapeutic Solutions International, Inc. Appoints Francesco Marincola to Scientific Advisory Board
CI
Therapeutic Solutions International, Inc., Appoints Juergen Winkler, MD, ABIHM to Scientific Advisory Board
CI
Therapeutic Solutions International Announces the Appointment of James Veltmeyer as Chief Medical Officer
CI
Therapeutic Solutions International, Inc., Announces the Appointment of Nassir Azimi to Scientific Advisory Board
CI
Therapeutic Solutions International, Inc. Appoints James Drew Veltmeyer to the Scientific Advisory Board
CI
Therapeutics Solutions International, Inc. Appoints Hong Ma as Chief Scientific Officer
CI
Therapeutic Solutions International, Inc. Appoints Thomas E. Ichim to Board of Directors
CI
Therapeutics Solutions International, Inc. Announces the Appointment of Dr. Barry Glassman to Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TSOI Stock
  4. News Therapeutic Solutions International, Inc.
  5. Insiders